Aidoc $150M round pushes enterprise imaging AI strategy
Aidoc said the round was led by Growth Equity at Goldman Sachs Alternatives and brings its total funding to more than $500M. The company plans to expand its CARE foundation model, aiOS enterprise platform, and automated imaging-report capabilities.
Aidoc has raised $150M in Series E funding to expand its clinical AI platform, according to the company. The round brings the company’s total funding to more than $500M.
Growth Equity at Goldman Sachs Alternatives led the financing, with participation from General Catalyst, SoftBank Investment Advisors, and NVentures, NVIDIA’s venture capital arm.
Capital from the round will go toward further development of CARE, Aidoc’s clinical foundation model, and broader deployment of aiOS, its enterprise AI platform.
Earlier this year, CARE received FDA clearance for what Aidoc described as a comprehensive foundation-model-based triage system in clinical imaging.
Automated imaging draft-report creation is also part of the company’s planned expansion, as Aidoc works toward end-to-end AI workflows across CT and X-ray.
Nearly 2,000 hospitals use Aidoc’s technology, which analyzes more than 60M patient cases annually, according to the company.
The company said hospitals are moving from single-use AI tools toward enterprise platforms that can manage multiple applications under centralized operating and governance frameworks.
Aidoc has received 31 FDA clearances across use cases that include emergency department triage and detection of conditions on abdominal scans.
Company:Aidoc
About the author
RadiologySignal.com writersEditorial Team
Radiology Signal Staff covers developments across medical imaging, radiology AI, imaging informatics, clinical research, and radiology business. The team monitors primary sources, peer-reviewed studies, company announcements, society updates, and healthcare industry news to deliver concise reporting for imaging professionals.
More from this section
Niowave Lansing site to scale Ac-225 supply by 2028
The Lansing, MI, site will house superconducting linear accelerators and radiochemistry systems to support scalable actinium-225 production, with completion expected in 2028.
30-year GE-UW tie expands into CT and theranostics research
The collaboration will focus on CT and molecular imaging technologies for cardiology, oncology, and theranostics workflows at UW Medicine Radiology facilities in Seattle.
Recall issues and isotope shortages weigh on Radnostix Q1 revenue
The radioisotope-focused company reported $2.38M in Q1 revenue, citing recall impacts, isotope shortages, and Cobalt-60 hot cell downtime.
Ephemeral to build AI data platform for Plus CNS oncology programs
The companies will develop an AI platform to integrate therapeutic, diagnostic, and bioinformatics data across Plus Therapeutics’ CNS oncology programs.
Fujifilm balloon-free EBUS scope targets pulmonary setup time
The EB-710US Ultrasound Bronchoscope is designed for pulmonary procedures and will be demonstrated at the American Thoracic Society Conference.
ACIST wins FDA clearance for Pro Diagnostic System
The Bracco company received U.S. clearance and launched ACIST Pro, a variable-rate contrast management system for image-guided cardiovascular procedures.
Braid Health launches $199 radiology second-opinion service
Patients can upload MRI, CT, X-ray, or ultrasound files and receive a written second opinion from a board-certified U.S. radiologist.
QT Imaging prices $10M raise for breast imaging platform
QT Imaging Holdings priced a $10M underwritten public offering of common stock and pre-funded warrants. The breast imaging technology company plans to use proceeds for working capital and general corporate purposes.
PSMA PET guidance anchors EDAP-Telix HIFU prostate work
EDAP TMS and Telix Pharmaceuticals signed a letter of intent to explore clinical research combining Focal One Robotic HIFU with Telix PSMA PET imaging agents in prostate cancer care.
UnitedHealthcare cites radiology costs in Maryland premium request
UnitedHealthcare is seeking an average 7.9% mid-year premium increase for some Maryland small-group plans. The insurer cited rising outpatient costs, including radiology, lab pathology, infusion, and radiation therapy.
Lumexa adds 4 imaging centers, including first UPMC JV site
Lumexa Imaging added 4 outpatient imaging centers across Pennsylvania, North Carolina, South Carolina, and Florida. The expansion includes acquired centers through joint ventures with UPMC and Advocate Health, plus 2 newly built locations.
PAI report finds 82% of U.S. physicians are now employed
A new PAI-Avalere report found that 82% of U.S. physicians are employed by hospitals, health systems, or corporate entities. Physician-owned settings now account for 18% of physicians and 36.1% of practices.